This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Debt-Ceiling Standoff Awakens Value Investors

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Aceto Corp. (ACET)

Company Profile: Aceto distributes chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and agrochemicals.

AFAM's Target Price: $13.32

Potential Upside From Current Levels: 113%

Clark's Take: International expansion has been the play on Aceto, as the company now derives almost 40% of its revenue from outside the U.S. Clark and his firm are also encouraged by the company's acquisition of Rising Pharmaceuticals, "which gives Aceto a presence as a developer and marketer of its own brand of pharmaceuticals."

"In addition, management expects to bring a number of new crop-protection products to market over the next few years," Clark says. "Aceto's balance sheet is still solid, post the added debt for the Rising acquisition. Shares, which carry a 3% yield, are trading slightly above book value and are attractively valued versus the company's historic earnings and sales multiples."






STMicroelectronics (STM - Get Report)

Company Profile: STMicroelectronics is a European-based global semiconductor manufacturer.

AFAM's Target Price: $19.70

Potential Upside From Current Levels: 150%

Clark's Take: STMicro shares are down nearly 25% this year as the company's wireless joint venture with Ericsson continues to drag on its strong momentum in its other core divisions. "Investors seem to be assigning STM's portion of the joint venture a negative value," Clark says.

However, Clark expects that either positive traction with the joint venture or an outright divesture could provide upside to the stock. "With a strong roadmap in products for automotive, consumer and industrial applications, STM is targeting faster market growth in 2011, and the company has proven it is more than willing to shed low-margin businesses," Clark says. "The firm's balance sheet and free cash flow should support the dividend, currently a rich 3.4%."

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

-- Written by Robert Holmes in Boston.



>To contact the writer of this article, click here: Robert Holmes.

>To follow Robert Holmes on Twitter, go to http://twitter.com/RobTheStreet.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
CHK $15.86 0.00%
DIS $110.81 0.00%
CTB $37.47 0.00%
E $38.26 0.00%
STM $7.57 0.00%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs